Special Issue | May 2018
In the next special issue of Pharma Technology Focus, we take a closer look at some of the latest developments in biotechnology, including the revolutionary gene-editing tool CRISPR, which is quickly emerging as a key tool for drug target identification, as well as preclinical testing.
We also consider what regulatory steps need to be taken to improve the US adoption of biosimilars as it flags behind Europe, examine how the biotech M&A landscape is likely to develop over the course of 2018, as large pharma firms look to pad their pipelines with new acquisitions, and sit down with Dotmatics to find out more about the latest version of the company’s data visualisation tool Vortex.
Finally, we ask whether artificial intelligence can be used to extract genomic data and discover relevant biomarkers, and learn more about a new method of manufacturing proteins outside of a cell.
Editor | Katie Woodward
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Elly Earls, Elliot Gardner, Chris Lo, Abi Millar
Magazine Designer | Lorena Martinez
Graphic Designers | Paulius Zutautas, Francesco Cianciulli, Marzia Compassi, Kate Cuntapay, Anett Arc, Sara Basto, Marzia Del Gaone
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Deputy Editor | Callum Tyndall
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Pharma Technology Focus is a product of Net Resources International. Copyright 2018 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registrationnumber 03171601.
All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.